Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report)’s stock price gapped down prior to trading on Thursday . Madrigal Pharmaceuticals shares last traded at $454.0720, with a volume of 263,073 shares changing hands. Piper Sandler restated an “overweight” rating on shares of Madrigal Pharmaceuticals in a research note on Wednesday, June 24th. Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Free Report) last issued its quarterly earnings data on Thursday, July 30th. Featured ArticlesReceive News & Ratings for Madrigal Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Madrigal Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.